Difference between revisions of "Anaesthesia"
Jump to navigation
Jump to search
| Line 98: | Line 98: | ||
**[[Non-Depolarising Neuromuscular Blockers|Non-Depolarising]] | **[[Non-Depolarising Neuromuscular Blockers|Non-Depolarising]] | ||
*[[Interventional Agents]] | *[[Interventional Agents]] | ||
| − | **[[Dobutamine]] | + | **[[Interventional_Agents#Dobutamine|Dobutamine]] |
| − | **[[Dopamine]] | + | **[[Interventional_Agents#Dopamine|Dopamine]] |
| − | **[[Ephedrine]] | + | **[[Interventional_Agents#Ephedrine|Ephedrine]] |
| − | **[[Phenylephrine]] | + | **[[Interventional_Agents#Phenylephrine|Phenylephrine]] |
| − | **[[Vasopressin]] | + | **[[Interventional_Agents#Vasopressin|Vasopressin]] |
====Special Cases==== | ====Special Cases==== | ||
*[[Cardiovascular Disease and Anaesthesia|Cardiovascular Disease ]] | *[[Cardiovascular Disease and Anaesthesia|Cardiovascular Disease ]] | ||
Revision as of 18:24, 8 September 2010
Anaesthesia Section
Content
Species Specific Considerations
Special considerations for animals with underlying diseases
Principles of AnalgesiaFluid TherapyAnaesthetic EquipmentMonitoring Anaesthesia
Species Specific Considerations |
Sedatives and TranquilisersAnaesthetic DrugsSpecial Cases |